These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 16393441)

  • 21. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis.
    Horak F; Unkauf M; Beckers C; Mittermaier EM
    Arzneimittelforschung; 2000 Dec; 50(12):1099-105. PubMed ID: 11190775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
    Howland WC; Amar NJ; Wheeler W; Sacks H
    Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis.
    Han D; Chen L; Cheng L; Liu S; Fu Z; Zhang W; Wang C; Xi L; Zhang L;
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(5):260-5. PubMed ID: 21832863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study.
    Duarte C; Baëhre M; Gharakhanian S; Leynadier F;
    J Investig Allergol Clin Immunol; 2001; 11(1):34-40. PubMed ID: 11436969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
    Horak F; Stübner P; Zieglmeyer R; Harris AG
    Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis.
    Gambardella R
    J Int Med Res; 1993; 21(5):268-75. PubMed ID: 7906659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential therapy with azelastine in seasonal allergic rhinitis. Deutsche Rhinitis Studiengruppe (German Rhinitis Study Group).
    Kremer B; Klimek L; Gülicher D; Degen M; Mösges R
    Arzneimittelforschung; 1999 Nov; 49(11):912-9. PubMed ID: 10604044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.
    LaForce C; Dockhorn RJ; Prenner BM; Chu TJ; Kraemer MJ; Widlitz MD; D'Eletto TA; Freitag JJ
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):181-8. PubMed ID: 8595539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE; Lumry WR; Anolik R
    J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P; Zieglmayer R; Horak F
    Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
    Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
    Chervinsky P; Nayak A; Rooklin A; Danzig M
    Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamber.
    Patel P; D'Andrea C; Sacks HJ
    Am J Rhinol; 2007; 21(4):499-503. PubMed ID: 17882923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.